Download full-text PDF

Source
http://dx.doi.org/10.1002/art.1780390734DOI Listing

Publication Analysis

Top Keywords

cytokines polymyalgia
4
polymyalgia rheumatica
4
cytokines
1
rheumatica
1

Similar Publications

Giant cell arteritis (GCA) is an autoimmune/autoinflammatory disease affecting large vessels in patients over 50 years old. The disease presents as an acute inflammatory response with two phenotypes, cranial GCA and large-vessel vasculitis (LV)-GCA, involving the thoracic aorta and its branches. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET-CT) is among the imaging techniques contributing to diagnosing patients with systemic disease.

View Article and Find Full Text PDF

We sought to clarify the musculoskeletal ultrasound (MSUS) findings and serum concentrations of cytokines/growth factors in glucocorticoid-resistant polymyalgia rheumatica (GC-R PMR). Patients with PMR admitted to Nagasaki University Hospital ( = 41) were enrolled. MSUS of both shoulder joints was performed in 36 patients.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers aimed to understand the role of CXC chemokine ligand 10 (CXCL10) in isolated polymyalgia rheumatica (PMR) by comparing its serum levels in PMR patients before and after treatment, as well as in rheumatoid arthritis (RA) patients and healthy individuals.
  • The study collected and analyzed serum samples from multiple patient groups over several years, using protein microarray technology and enzyme-linked immunosorbent assay (ELISA) to measure various cytokines, particularly focusing on CXCL10.
  • Results showed that CXCL10 levels were significantly higher in active PMR patients compared to those in remission, RA patients, and healthy controls, suggesting it may be important in PMR pathogenesis and
View Article and Find Full Text PDF
Article Synopsis
  • Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are inflammatory diseases, and researchers are looking for biomarkers to identify active cases and those who may need alternative treatments to glucocorticoids.
  • A study evaluated the presence of interferon type I (IFN-I) markers in GCA and PMR patients, including those not previously treated, but did not find significant differences in IFN-I scores between these groups and healthy controls.
  • The results indicated that the IFN-I signature and serum markers CXCL10 and Galactin-9 were not elevated in patients with GCA or PMR, suggesting that these IFN-I markers may not be useful for diagnosing or guiding treatment
View Article and Find Full Text PDF
Article Synopsis
  • Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) often overlap, but PMR lacks the vascular inflammation present in GCA, suggesting different underlying mechanisms.
  • *In a study involving 45 isolated PMR patients and 29 PMR/GCA overlap patients, various serum biomarkers related to inflammation and vascular function were measured to differentiate between the two conditions before starting treatment.
  • *Results indicated that certain biomarker ratios, specifically CXCL9/IL-6 and MMP-3/sCD141, were more effective at diagnosing GCA in patients with isolated PMR, demonstrating the potential to guide further examination for those at risk.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!